Skip to content
10-Q

Quarterly Report

MEDICUS SCIENCES ACQUISITION CORP.

0001104659-22-089384

← back to feed
Filed
Aug 11, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$368.44K
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$536.37K
Cash And Equivalents Q2 2022 · Jun 30, 2022 $1.07M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $1.43M
Current Liabilities Q2 2022 · Jun 30, 2022 $21.42K
Current Liabilities Q2 2022 · Dec 31, 2021 $32.01K
Total Liabilities Q2 2022 · Jun 30, 2022 $4.21M
Total Liabilities Q2 2022 · Dec 31, 2021 $8.27M
Current Assets Q2 2022 · Jun 30, 2022 $1.19M
Current Assets Q2 2022 · Dec 31, 2021 $1.58M
Total Assets Q2 2022 · Jun 30, 2022 $93.39M
Total Assets Q2 2022 · Dec 31, 2021 $93.62M
Net Income Q2 2022 · Jun 30, 2022 $1.57M
Net Income Q2 2022 · Jun 30, 2022 $3.82M
Net Income Q2 2022 · Mar 31, 2022 $2.25M
Net Income Q2 2022 · Jun 30, 2021 −$1.54M
Net Income Q2 2022 · Jun 30, 2021 −$96.66K
Net Income Q2 2022 · Mar 31, 2021 $1.45M
Operating Income Q2 2022 · Jun 30, 2022 −$174.94K
Operating Income Q2 2022 · Jun 30, 2022 −$384.07K
Operating Income Q2 2022 · Jun 30, 2021 −$192.43K
Operating Income Q2 2022 · Jun 30, 2021 −$301.79K
Stockholders Equity Q2 2022 · Mar 31, 2022 −$4.39M
Stockholders Equity Q2 2022 · Dec 31, 2021 −$6.64M
Stockholders Equity restated Q2 2022 · Jun 30, 2021 −$8.64M
Stockholders Equity restated Q2 2022 · Mar 31, 2021 −$7.09M
Stockholders Equity Q2 2022 · Dec 31, 2020 $18.93K